Aiforia Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Public

  • Employees
  • 75

Employees

  • Stock Symbol
  • AIFORIA

Stock Symbol

  • Share Price
  • $3.89
  • (As of Thursday Closing)

Aiforia General Information

Description

Aiforia Technologies PLC equips pathologists and scientists in preclinical and clinical labs with powerful deep learning artificial intelligence software for translating images into discoveries, decisions, and diagnoses. The cloud based Aiforia products and services plan to escalate the efficiency and precision of medical image analysis beyond current capabilities, across a variety of fields from oncology to neuroscience and more.

Contact Information

Website
www.aiforia.com
Formerly Known As
Fimmic, Webmicroscope
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Pursimiehenkatu 29-31 D
  • Tukholmankatu 8
  • 00150 Helsinki
  • Finland
+358 020
Primary Industry
Decision/Risk Analysis
Stock Exchange
HEL
Corporate Office
  • Pursimiehenkatu 29-31 D
  • Tukholmankatu 8
  • 00150 Helsinki
  • Finland
+358 020

Aiforia Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aiforia Stock Performance

As of 22-May-2025, Aiforia’s stock price is $3.89. Its current market cap is $113M with 29M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.89 $3.93 $3.42 - $5.26 $113M 29M 24.4K -$0.47

Aiforia Financials Summary

As of 31-Dec-2024, Aiforia has a trailing 12-month revenue of $3.09M.

In Thousands,
USD
TTM 31-Dec-2024 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 93,721 93,721 83,491 57,953
Revenue 3,086 3,086 2,595 1,689
EBITDA (8,425) (8,425) (10,760) (10,294)
Net Income (12,928) (12,928) (13,986) (12,781)
Total Assets 29,527 29,527 31,162 39,119
Total Debt 6,828 6,828 6,463 3,984
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Aiforia Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Aiforia‘s full profile, request access.

Request a free trial

Aiforia Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Aiforia‘s full profile, request access.

Request a free trial

Aiforia Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Aiforia Technologies PLC equips pathologists and scientists in preclinical and clinical labs with powerful deep learning
Decision/Risk Analysis
Helsinki, Finland
75 As of 2024

Singapore, Singapore
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aiforia Competitors (4)

One of Aiforia’s 4 competitors is HistoIndex, a Venture Capital-Backed company based in Singapore, Singapore.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
HistoIndex Venture Capital-Backed Singapore, Singapore
Biofourmis Formerly VC-backed Boston, MA
Fibronostics Venture Capital-Backed Indian Harbour Beach, FL
Quanterix Formerly PE-Backed Billerica, MA
To view Aiforia’s complete competitors history, request access »

Aiforia Patents

Aiforia Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230016641-A1 Processing pathology images Active 13-Jul-2021
US-11373306-B1 Processing pathology images Active 13-Jul-2021
US-20230124391-A1 Processing pathology images Active 13-Jul-2021
US-11562485-B1 Processing pathology images Active 13-Jul-2021
US-20230342930-A1 Processing pathology images Active 13-Jul-2021 G06T7/0012
To view Aiforia’s complete patent history, request access »

Aiforia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aiforia Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Aiforia‘s full profile, request access.

Request a free trial

Aiforia FAQs

  • When was Aiforia founded?

    Aiforia was founded in 2013.

  • Where is Aiforia headquartered?

    Aiforia is headquartered in Helsinki, Finland.

  • What is the size of Aiforia?

    Aiforia has 75 total employees.

  • What industry is Aiforia in?

    Aiforia’s primary industry is Decision/Risk Analysis.

  • Is Aiforia a private or public company?

    Aiforia is a Public company.

  • What is Aiforia’s stock symbol?

    The ticker symbol for Aiforia is AIFORIA.

  • What is the current stock price of Aiforia?

    As of 22-May-2025 the stock price of Aiforia is $3.89.

  • What is the current market cap of Aiforia?

    The current market capitalization of Aiforia is $113M.

  • What is Aiforia’s current revenue?

    The trailing twelve month revenue for Aiforia is $3.09M.

  • Who are Aiforia’s competitors?

    HistoIndex, Biofourmis, Fibronostics, and Quanterix are competitors of Aiforia.

  • What is Aiforia’s annual earnings per share (EPS)?

    Aiforia’s EPS for 12 months was -$0.47.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »